SCHEMBL3420195

SCHEMBL3420195

C1=Cc2ccc(-c3ccccc3)cc2CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 1/20 0.39
PARP11 Q9NR21 1/20 0.39
TDP2 O95551 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
FFAR4 Q5NUL3 1/20 0.35
ALOX5 P09917 1/20 0.35
KDM4E B2RXH2 3/20 0.35
MEN1 O00255 3/20 0.35
MAPT P10636 3/20 0.35
KMT2A Q03164 3/20 0.35
NPC1 O15118 2/20 0.35
GAA P10253 2/20 0.35
RXFP1 Q9HBX9 1/20 0.35
KDM1A O60341 3/20 0.35
KDM1B Q8NB78 1/20 0.35
TYRO3 Q06418 1/20 0.34
NTRK2 Q16620 1/20 0.34
CLK4 Q9HAZ1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22073568 0.89 MAOA (0.41) PARP10PARP11TDP2CYP1A2CYP11B1
SCHEMBL7122408 0.85 TYRO3 (0.38) PARP10PARP11TDP2ALOX5KDM4E
SCHEMBL23180439 0.85 CYP1A2 (0.38) PARP10PARP11TDP2CYP1A2CYP11B1
SCHEMBL20403501 0.85 CHKA (0.35) PARP10PARP11FFAR4MEN1KMT2A
SCHEMBL20940419 0.84 L3MBTL1 (0.50) PARP10PARP11CYP1A2CYP11B1CYP11B2
SCHEMBL13699098 0.84 FFAR4 (0.33) CYP1A2CYP11B1CYP11B2FFAR4
SCHEMBL13289258 0.81 TAAR1 (0.33) SMN1; SMN2LMNAHSP90AA1
SCHEMBL27010852 0.81 PLA2G2A (0.40) CYP1A2KDM4EMEN1MAPTKMT2A
SCHEMBL4126787 0.81 TDP2 (0.39) PARP10PARP11TDP2ALOX5KDM4E
SCHEMBL28757992 0.81 PARP10 (0.41) PARP10PARP11TDP2CYP1A2CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105017037-B 6 substituted aryl amino methyl tetrahydro naphthaline derivatives or its esters, and its production and use 复旦大学 2018-01-19 CN disclosed
US-8357821-B2 Aromatic amine compound, organic electroluminescent element including the same, and display device including organic electroluminescent element SONY CORPORATION (JP) 2013-01-22 US disclosed
CN-101735107-A Aromatic amine compound, organic electroluminescent element including the same, and display device including organic electroluminescent element SONY CORP 2010-06-16 CN disclosed
US-20100109555-A1 AROMATIC AMINE COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING ORGANIC ELECTROLUMINESCENT ELEMENT SONY CORPORATION (JP) 2010-05-06 US disclosed
US-4386007-A ELECTROOPTIC DISPLAY MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1983-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100109555-A1 AROMATIC AMINE COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING ORGANIC ELECTROLUMINESCENT ELEMENT AOC2, NR2E1, AOC3 PARP10 3341/4885PARP11 2508/4885TDP2 2717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.